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ABSTRACT
The nuclear cap-binding protein complex (CBC)
participates in 50 splice site selection of introns
that are proximal to the mRNA cap. However, it is
not known whether CBC has a role in alternative
splicing. Using an RT–PCR alternative splicing
panel, we analysed 435 alternative splicing events
in Arabidopsis thaliana genes, encoding mainly tran-
scription factors, splicing factors and stress-related
proteins. Splicing profiles were determined in wild
type plants, the cbp20 and cbp80(abh1) single
mutants and the cbp20/80 double mutant. The alter-
native splicing events included alternative 50 and 30
splice site selection, exon skipping and intron reten-
tion. Significant changes in the ratios of alternative
splicing isoforms were found in 101 genes. Of these,
41% were common to all three CBC mutants and
15% were observed only in the double mutant. The
cbp80(abh1) and cbp20/80 mutants had many more
changes in alternative splicing in common than did
cbp20 and cbp20/80 suggesting that CBP80 plays a
more significant role in alternative splicing than
CBP20, probably being a platform for interactions
with other splicing factors. Cap-binding proteins
and the CBC are therefore directly involved in alter-
native splicing of some Arabidopsis genes and in
most cases influenced alternative splicing of the
first intron, particularly at the 50 splice site.
INTRODUCTION
Alternative splicing is a widespread process that generates
more than one spliced mRNA isoform from the same gene
and expands both transcriptome and proteome diversity.
Alternative events include alternative 50 and 30 splice site
selection, intron retention, exon skipping and mutually
exclusive exon splicing (1–3). Current estimates from
both experimental and bioinformatic analyses are that
30–35% of Arabidopsis thaliana and rice genes undergo
alternative splicing (4,5), while in human up to 95% of
multi-exon genes undergo alternative splicing (6). The
number of alternatively spliced plant genes is still likely
to be an underestimate because of the relatively low
EST coverage and depth of sequencing for many plant
transcripts (5). In addition, many alternative splicing
events occur only in speciﬁc cells and tissues, at speciﬁc
stages of development and/or under certain physiological
conditions and are therefore under-represented in EST
databases. In plants, intron retention is the most
frequent alternative event (45–56% of A. thaliana alterna-
tive splicing events) (4,7–10). Alternative 30 and 50 splice
site selection accounts for  22 and 10% of events, respec-
tively, and  4% have both 50 and 30 alternatively spliced
sites. Only 8% of alternative splicing events in plants
involve exon skipping (inclusion/exclusion of an exon) in
contrast to animals where exon skipping is the most
common form of alternative splicing (58% of genes)
(8,11,12). The two major consequences of alternative
splicing are to increase protein diversity by the inclusion
or exclusion of peptide sequences or protein domains or
to modulate gene expression through the production of
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mediated decay (NMD). More than 75% of alternative
splicing events are within the coding sequence of the
gene and can generate proteins with new structures and
biological functions (2,8,13). However, in both plants and
animals, a signiﬁcant number of AS events in the coding
regions have a premature termination codon and are the
potential targets of NMD (8,14,15). In plants,  21% of all
alternative splicing events take place within the 50 UTR
(15%) or 30 UTR (6%) which can aﬀect transport and
stability of mRNAs, create new initiation codons or
polyadenylation sites, generate upstream open reading
frames or shift the reading frame (7,11). Regulation of
alternative splicing in plants has been reported for many
genes and evolutionary conserved regulation of alternative
splicing of plant SR proteins which themselves are splicing
regulators points to important rolesof alternative splicing
in plant development (16). For example, the circadian
clock RNA-binding protein, AtGRP7, autoregulates its
transcript levels by binding its pre-mRNA to cause alter-
native splicing and generate an isoform that is turned over
by NMD (17). The rice Waxy gene encodes a granule-
bound starch synthase for which alternative splicing is
temperature sensitive, potentially contributing to poor
grain quality when seed maturation occurs at low temper-
ature (18). Alternative splicing of the ﬁrst intron of the
isoaspartyl methyltransferase 2 gene creates diﬀerent
protein variants found in diﬀerent subcellular compart-
ments where they are involved in protein repair processes
(19). Some transcripts can be alternatively spliced in plants
in response to wounding or virus infection (20–22). Alter-
native splicing can also be regulated in a temperature-
dependent manner, such as the A. thaliana SR1 splicing
factor (23), or in a tissue-dependent manner, for example,
tobacco RGP (24) and spinach and tobacco chloroplast
ascorbate peroxidase transcripts (25).
The eukaryotic nuclear cap-binding complex (CBC)
consists of two subunits (CBP20 and CBP80) that, as a
complex, bind to the cap structure of RNA polymerase
II transcripts (26). The cap and the CBC have multiple
functions in mRNA biogenesis including splicing (26–31),
30-end formation by stabilizing the interaction of the 30-end
processing machinery (32,33), nuclear export (34–37) and
protection of the transcripts from nuclease degradation
(38–39). Constitutive and alternative splicing is mediated
by the spliceosome which is assembled on an intron in a
stepwise process. An early event in spliceosome assembly is
the interaction of U1snRNP with the 50 splice site of the
intron. In mammals and yeast, the CBC at the 50-end of the
pre-mRNA transcript promotes the initial interaction
between U1snRNP and the 50 splice site of the ﬁrst
intron in the transcript, and enhances the formation of
spliced mRNAs (26–31,40–44). CBP proteins remain
bound to the mRNA during the pioneer round of transla-
tion playing an essential role in mRNA quality control
(45). Moreover, in mammalian cells, CBP80 recruits the
NMD factor Upf1 and promotes the interaction of Upf1
with the NMD factor Upf2 (46).
The plant CBC also consists of two subunits: AtCBP20
and AtCBP80. AtCBP20 has a calculated molecular mass
of 29.9kDa and exhibits 68% identity and 82% similarity
to its human orthologue and 53% identity and 77% sim-
ilarity to the yeast protein. The larger CBP80 subunit is
96.5kDa and exhibits lower identity (28 and 22%) and
similarity (50 and 42%) to its human and yeast ortho-
logues, respectively. AtCBP20 contains a canonical RNA
binding domain (RBD) and AtCBP80 contains a protein–
protein and protein–nucleic acid interaction domain,
MIF4G (47). Additionally, in contrast to human and
yeast, AtCBP20 has a long C-terminal extension with two
nuclear localisation signals (NLSs) and is actively trans-
ported to the nucleus, while AtCBP80 can reach the
nucleus only in a complex with AtCBP20. This feature
distinguishes the mechanism of CBP transport in plants
and animals where the nuclear import of human CBC
requires a bipartite NLS on CBP80 (48). Moreover,
neither CBP20 nor CBP80 is involved in NMD in
A. thaliana (49).
Both plant CBC proteins are encoded by single-copy
genes on Arabidopsis chromosomes V and II, respectively
(47) and T-DNA insertion mutants which disrupt either
the AtCBP20 or AtCBP80(ABH1) genes show identical
phenotypes: slow growth and serrated leaf margins. Both
mutants are abscisic acid (ABA) hypersensitive and can
tolerate water deﬁciency much better than wild type plants
(50–53). The mutants also aﬀect ﬂowering time and the
processing and splicing of mRNA of factors involved in
the regulation of ﬂowering time in Arabidopsis is aﬀected
(41,54,55). The increase in the occurrence of unspliced
introns demonstrates a further eﬀect of the CBC on
pre-mRNA splicing (40,41,56). Finally, the plant CBC
has recently been shown to mediate the biogenesis
of microRNAs (miRNA) (40,53,57). Both cbp20 and
cbp80(abh1) mutants have reduced miRNA levels and
increased pri-miRNA levels. CBP20 and CBP80 are
suggested to bind to capped pri-miRNA transcripts and
play role in their processing (53). The CBC interaction
with the miRNA processing machinery appears to
involve SERRATE (40) and is likely to facilitate the
loading of the miRNA processing machinery onto pri-
miRNA, in analogy with its role in recruiting the
splicing commitment complex onto pre-mRNA (40,57).
The role of CBP80 in miRNA-mediated RNA silencing
pathway may also be conserved in animals (58). Finally,
both proteins also participate in ta-siRNA biogenesis
through regulating the biogenesis of miR173 and
miR390 (53).
The CBC is important in pre-mRNA splicing and other
aspects of RNA processing in plants. To date, there is no
evidence that the nuclear cap-binding complex is involved
in alternative splicing and whether the plant CBC exerts
an eﬀect on splicing by a similar mechanism to animals—
promoting spliceosome assembly on the ﬁrst intron—is
unknown. In this article, we have addressed the inﬂuence
of the nuclear cap-binding complex on alternative splicing
of 252 A. thaliana gene transcripts showing alternative
splicing, using the T-DNA insertion knock-out mutants:
the single cbp20 and cbp80(abh1) mutants and the double
cbp20/80 mutant. In the cases that showed signiﬁcant
changes in AS, the mutants preferentially aﬀect alternative
splicing of the ﬁrst intron and particularly at the 50 splice
site. Similar changes in the alternative splicing proﬁles of
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mutants suggesting that the CBC is directly involved in
alternative splicing of these pre-mRNAs. Interestingly,
our results revealed that AtCBP80 plays a more signiﬁcant
role in alternative splicing than AtCBP20.
MATERIALS AND METHODS
Plant material and growth conditions
Arabidopsis thaliana (wild-type Columbia and cbp mutant)
seeds were placed in a bell-jar and sterilised using hydro-
chloric acid fumes generated from a solution containing
100ml ACE bleach (5.25% v/v, Procter and Gamble) and
3ml concentrated HCl. Sterilised seeds were sown in soil
treated with Amistar fungicide (Syngenta), and were kept
at 4 C for 72hin the dark. After vernalisation, plants were
grown in a growth chamber (SANYO MLR-350H) under
controlled environmental parameters: 70% humidity, tem-
perature 22 C, 16h light/8h dark photoperiod regime at
150–200mE/m
2. Five-week-old plants were harvested and
leaf tissue was ﬂash frozen in liquid nitrogen and stored at
 80 C. The A. thaliana wild-type Columbia was originally
obtained from Lehle Seeds; the cbp20 and cbp80(abh1)
mutants were as described in Papp et al. (52) and
Hugouvieux et al. (50), respectively. The cbp20/80
double mutant was obtained by crossing cbp20 and
cbp80(abh1), and the homozygous line was isolated
based on PCR assays.
RNA extraction and RT–PCR
Total RNA was extracted from 100mg, ﬁve-week-old
leaves using the RNeasy Plant Mini Kit (Qiagen) and
quantiﬁed spectrophotometrically at 260nm. RT–PCR
experiments were performed on total RNA isolated after
DNase RQ1 treatment, according to the manufacturer’s
instructions (Promega). Reverse transcription by M-MLV
RT (RNase H-) (Promega) was performed using oligo
d(T)
18 oligonucleotide as a primer. First, 5mg of extracted
RNA and 1ml oligo d(T)
18 (10mM) were mixed in a total
volume of 26ml, incubated for 5min at 65 C to melt sec-
ondary structures within the template, and cooled imme-
diately for 10min on ice. Subsequently, 8ml M-MLV 5 
Reaction Buﬀer, 1ml M-MLV (RNase H-) (200U/ml), 4ml
nucleotide mix (10mM each dNTP) and 1ml RNasin
(40U/ml) (Promega) were added to form a 40ml volume
reaction mix. The reaction mix was incubated for 1.5h at
42 C and further incubated at 70 C for 10min to inacti-
vate the reverse transcriptase. The reverse transcription
reaction was diluted to a ﬁnal volume of 100ml, and 1ml
cDNA was then aliquoted into a reaction tube along
with 2.5ml1 0   PCR buﬀer with MgCl2 (Roche), 4ml
nucleotide mix (1.25mM of each dNTP, Promega),
0.75ml of combined alternative splicing event-speciﬁc
primers (100mM stock) and Taq DNA Polymerase
(5U/ml, Roche). A 25-ml volume PCR reaction mix was
then subjected to the standard PCR reaction: 94 C for
2min, followed by 24 cycles of 94 C for 15s, 50 C for
30s, 70 C for 1min and completed with 10min at 72 C.
We have shown previously that 24 PCR cycles is in the
exponential ampliﬁcation range for mRNA transcripts of
numerous genes with a range of expression levels (59). AS-
speciﬁc primers were selected to amplify the expected
alternative spliced mRNA isoforms, and gave RT–PCR
products of sizes between 60 and 700bp. In order to visu-
alize the RT–PCR products, the forward primer was
labelled with one of the following dyes: 6-FAM, VIC,
NED or PET (Applied Biosystems). Primer sequences
are given in Supplementary Table S1.
Splicing analysis
Labelled RT–PCR product (1ml) from the RT–PCR
reactions was mixed with 8.95ml Hi Di Formamide
(Applied Biosystems) and with 0.05ml of GeneScan 500
LIZ or GeneScan 600 LIZ internal size standard
(Applied Biosystems). Using an ABI3730 DNA Analyzer
(Applied Biosystems), capillary electrophoresis of RT–
PCR fragments was performed. Peak size and area data
was analysed with GeneMapper or PeakScanner software
(Applied Biosystems). RT–PCR products were accurately
identiﬁed with ±1nt resolution. The relative ﬂuorescent
peak areas for RT–PCR products with expected sizes for
the alternatively spliced products were extracted, and a
ratio for the AS events was calculated by dividing the
value for the spliced products by the sum of the values
for the alternatively spliced products. For an accurate
measurement of AS ratios, three biological repeats were
performed for all experiments. Mean alternative splicing
eﬃciencies with standard errors were calculated for three
separate biological repetitions. Means were compared by
analysis of variance between wild type plants and the
diﬀerent CBP mutant lines and P-values generated. AS
events with signiﬁcant variation (P<0.10) were selected.
RESULTS
Alternative splicing RT–PCR panel
The inﬂuence of nuclear cap-binding proteins was
examined by analyzing 435 Arabidopsis alternative
splicing events on a custom high resolution RT–PCR
panel. The AS RT–PCR panel was based on that
described previously which contained 89 AS events and
seven controls (59). This panel was expanded to contain
428 AS events and seven controls. The AS events were in
transcripts from genes encoding transcription factors
(179), splicing factors (88), stress-related proteins (ABA)
(51), stomatal ABA signaling (10), ﬂowering time regu-
lating proteins (16) and other miscellaneous proteins
(91). The events were selected from either published AS
events or from ﬁve diﬀerent Arabidopsis/plant bioinfor-
matics databases: ASIP (http://www.plantgdb.org/ASIP/
EnterDB.php), TIGR (http://www.tigr.org/tdb/e2k1/
ath1/), RIKEN (http://rarge.gsc.riken.jp/a_splicing/index
.pl), ASTRA (http://alterna.cbrc.jp/) and TAIR 7.0
(http://www.arabidopsis.org/index.jsp). Seven genes were
used as controls and ampliﬁed intronless regions
(At5g03240, At5g60670, At3g61860), constitutively
spliced introns (At3g12110, At5g13480) or a U12-depen-
dent intron (At4g02560). Additionally, RuBisCo activase
(At2g39730) is an alternative splicing control that con-
sistently shows equal selection of two alternative 30
Nucleic AcidsResearch, 2010, Vol.38,No. 1 267splice sites in transcripts in all the tissues tested so far and
was used as an alternative splicing control.
The splicing proﬁles were determined by RT–PCR with
ﬂuorescently labelled primers for each AS event using
total RNA from wild type plants and from the single
mutants: cbp20 and cbp80(abh1) and the double mutant:
cbp20/80. The double mutant has a similar phenotype to
the single mutants: slow growth and serrated leaf margins,
ABA hypersensitivity and greater resistance to water
deﬁciency than wild type plants. PCR products were
separated on an ABI3730 automated DNA sequencer
and analysed by GeneMapper or PeakScanner software
(Applied Biosystems). The ratio of the peak areas of the
alternatively spliced isoforms for each gene in the wild
type plant was compared to the ratio of the peak areas
of products in the cbp mutants. Means and standard
errors were calculated for three separate experiments.
Alternative splicing is aﬀected in cbp mutants
Of the 435 genes tested, 99 genes did not show RT–PCR
products. This is most likely to be due to very low level of
expression of these particular genes in the plant tissue
analysed (35-days-old leaves). For 84 cases only one
splicing isoform was observed. This suggested that the
alternative splicing events did not occur in the tissue and
developmental stage analysed or represented extremely
rare events even though supported by EST/cDNA
sequences. As neither of the above groups provide alter-
native splicing information in the tissue analysed, these
events were not included in further analysis.
Of the 252 remaining diﬀerent AS events 101 showed
signiﬁcant (P 0.10) changes in the ratio of alternatively
spliced isoforms of over 3% between wild type plants and
the cbp20, cbp80(abh1) or cbp20/80 mutants. Of these
events, 41 were common to all three mutants, nine were
found in both the cbp80(abh1) and cbp20/80 mutants,
four were common to cbp20 and cbp20/80, ﬁve were
common to cbp20 and cbp80(abh1), 15 were found only
in the double mutant, and 6 and 21 only in the single
cbp20 and cbp80(abh1) mutants, respectively (Figure 1).
Diﬀerent types of alternative splicing events were aﬀected
in the cbp mutants (Table 1). The majority of the alterna-
tive splicing events involved two alternative products
(Table 2) and four events involved three alternative
products (Table 3). Thus, the majority of AS events
showing signiﬁcant changes in alternative splicing
proﬁles (41 events—41%) were found in all three cbp
mutants. For example, in At5g43270, both single
mutants showed a similar signiﬁcant change in AS but
the largest change was seen in the double mutant where
the ratio of the two alternatively spliced isoforms changed
from 76%:24% to 51%:49% (Figure 2A). In At1g31500,
the degree of change was similar in all three mutants
changing from 61%:39% to  70%:30% (Figure 2B).
In At5g02470, there were diﬀerent degrees of signiﬁcant
changes in all three mutants but again the biggest change
in the ratio of AS1:AS2 was in the double mutant (from
53:47 to 80:20%) (Figure 2C). Knocking out the CBC
could potentially have a general aﬀect on mRNA stability
leading to the observed changes in alternative splicing. We
therefore analysed by microarray analysis the expression
levels of genes in the cbp20 and cbp80 mutants com-
pared to wild-type. Across all genes, >97% showed no
diﬀerences in expression and in the genes containing the
101 signiﬁcantly diﬀerent alternative splicing events, only
one had a reduced expression level and two had increased
expression (data not shown). Thus, the CBC directly
inﬂuences the selection of alternative splice sites and the
extent and pattern of changes varied among the AS events
and the diﬀerent mutants.
Alternative splicing is mainly aﬀected in the cbp80 and
cbp20/80 double mutants
Forty-one AS events were signiﬁcantly changed in all three
cbp mutants. Of the remaining 60 events which showed
Table 1. Distribution of diﬀerent alternative splicing events with signiﬁcantly changed alternative splicing proﬁle among the cbp mutants
Alternative splicing event
Gene number Alt 30 splice site Alt 50 splice site Exon skipping Alternative position Intron retention
All cbp mutants 41 20 18 3 0 0
cbp80 plus cbp20/80 94 1 2 1 1
cbp20/80 15 9 3 1 0 2
cbp80 21 9 5 2 2 3
cbp20 plus cbp80 55 0 0 0 0
cbp20 63 3 0 0 0
cbp20 plus cbp20/80 43 0 1 0 0
Total 101 53 30 9 3 6
cbp20/80
0 8 p b c 0 2 p b c
41
15
9 4
6 21
5
Figure 1. Distribution of alternative splicing events with signiﬁcant
changes in alternative splicing proﬁles in the cbp mutants.
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Nucleic AcidsResearch, 2010, Vol.38,No. 1 271changes in either two out of three mutants or only in one
of them (Figure 1), only six events involved the cbp20
mutant while 21 and 15 events involved either
the cbp80(abh1) or the cbp20/80 mutants, respectively
(Figure 1). In addition, nine events with signiﬁcant
changes in alternative splicing were common to the
cbp80 and cbp20/80 mutants such that the majority of
events aﬀected in the cbp mutants were found in the
cbp80 and cbp20/80 double mutants.
cbp mutants preferentially aﬀect alternative splicing
in the ﬁrst intron
The CBC in animal and yeast systems promotes an eﬃ-
cient interaction between U1snRNP and the ﬁrst intron,
and enhances production of spliced mRNAs (29,30). To
examine whether Arabidopsis nuclear cap-binding proteins
also aﬀected the ﬁrst intron of transcripts, we compared
the position of the introns aﬀected by alternative splicing
in the total number of events (252), the events which
showed a signiﬁcant change at least one of the mutants
(101) (Figure 1) and those events which showed a signif-
icant change in alternative splicing in all three mutants
(41). Among the 252 events showing alternative splicing
on the RT–PCR panel, 107 events (42%) involved the ﬁrst
intron in the gene transcript, 102 (40%) involved an
internal intron and 43 (17%) involved the last intron in
the transcript (Figure 3). In the group of 101 AS events
with a signiﬁcantly diﬀerent alternative splicing proﬁle in
at least one mutant 50% are alternatively spliced in the
ﬁrst intron, whereas 33 and 18% are alternatively spliced
in the internal intron and the last intron of transcripts,
respectively. Interestingly, of the 41 events which showed
signiﬁcant changes in alternative splicing in all three
mutants, the ﬁrst intron was alternatively spliced in 23
of the events (56%) (Figure 3). Only 19.5% involved
internal introns and 24% involved the last intron. Thus,
the percentage of alternatively spliced ﬁrst and internal
introns diﬀers signiﬁcantly between the total number of
AS events analysed and those with signiﬁcant changes in
the three cbp mutants. The percentage of AS events
involving the last intron increased in the AS events
which were signiﬁcantly diﬀerent in all three mutants
(Figure 3). These results indicate that for those genes
where mutation of the CBC aﬀected alternative splicing,
the CBC is preferentially involved in alternative splicing of
the ﬁrst intron. In most cases (93%), the alternative ﬁrst
introns are located within the 50UTRs or span the 50UTR
and coding sequence of the genes studied.
cbp mutants preferentially aﬀect alternative 50 splice
site selection
Since the CBC promotes an eﬃcient interaction between
U1snRNP and the 50 site of the ﬁrst intron during consti-
tutive splicing, we asked whether the CBC can also inﬂu-
ence the selection between distal or proximal alternative 50
splice sites during alternative splicing. First, we compared
the number of events involving alternative 50 splice site
selection among all of the events showing alternative
splicing (252), in those where AS proﬁles changed
in at least one mutant (101) or in all three mutants (41).
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272 Nucleic Acids Research, 2010,Vol. 38,No. 1Of the 252 AS events, 75 (30%) involved selection of alter-
native 50 splice sites (Figure 4A). Similarly, of the 101
AS events changed in at least one mutant plant only 30
(30%) of AS events involved 50 splice sites. Interestingly,
a greater proportion of the events where alternative
splicing changed in all three mutants (18 of the 41
events—44%), involved alternative 50 splice sites with
fewer events involving alternative 30 splice site selection
(Figure 4A).
Second, we looked at the number of alternative 50 splice
site selection events among those involving the ﬁrst intron.
These groups consisted of 107 of the 252 total AS events,
50 of the 101 AS events changed in at least one cbp mutant
and 23 of the 41 AS events with signiﬁcant changes in all
three mutants. Of the 107 ﬁrst intron events, 36 (34%)
involved alternative 50 splice site selection. Similarly, of
the 50 AS events changed in at least one cbp mutant, 16
(32%) involved 50 splice site selection. Finally, of the 23
ﬁrst intron events with signiﬁcant AS changes in all three
cbp mutants, 11 (48%) involved alternative 50 splice site
selection (Figure 4B). Thus, both the total number of
alternative splicing events which are changed in all
three mutants and those which aﬀect the ﬁrst intron are
enriched in alternative 50 splice site selection. This change
in distribution suggests that CBC proteins are pre-
ferentially, but not exclusively, involved in the regulation
of alternative 50 splice site selection in the ﬁrst intron.
As the CBC preferentially aﬀects alternative 50 splice
selection in the ﬁrst intron of transcripts, we examined
whether the CBC also inﬂuenced the selection of the alter-
native 50 splice site. If the CBC promoted usage of the 50
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Nucleic AcidsResearch, 2010, Vol.38,No. 1 273splice site nearest to it, these events would be expected to
predominantly use the 50 splice site proximal to the cap.
A total of 16 AS events involved alternative 50 splice sites
in the ﬁrst intron and showed signiﬁcant changes in all
three mutants (11 events) or in one mutant (ﬁve events)
(Table 4). Of these, seven preferentially used the 50 splice
site closest to the cap in wild type plants, seven used the
cap-distal site and two used both sites equally. This
suggests that there is no preference for selection of either
cap-proximal or cap-distal sites in ﬁrst intron. The splicing
behaviour of these events in the absence of the CBC
followed two basic and subtly diﬀerent patterns. In the
ﬁrst case, in the wild type, the CBC preferentially
promoted selection of either the cap-proximal or the
cap-distal site to generate more of the major alternative
splicing isoform. In the knock-out mutants, the use of
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Figure 4. Percentage distribution of alternative splicing phenotypes.
The alternative splicing phenotypes are presented for (A) the total
events showing alternative splicing (252 AS events), AS events which
changed in at least one mutant plant (101 AS events) and those which
showed signiﬁcant changes in all three cbp mutants (41 AS events) and
(B) the total events involving the ﬁrst intron (107 AS events), AS events
changed in the ﬁrst intron in at least one mutant plant (50 AS events)
and those with signiﬁcant changes in the three cbp mutants which
involved the ﬁrst intron (23 AS events). ES—exon skipping; Alt 50—
alternative 50 splice site; Alt 30—alternative 30 splice site; AltP—events
involving both alternative 50 and 30 splice sites; IR—intron retention.
274 Nucleic Acids Research, 2010,Vol. 38,No. 1these sites were reduced increasing the amount of the
minor isoform. Thus, although both sites were used,
the CBC preferentially used one or other of the 50 splice
sites. Six of the 16 events followed this pattern (Table 4—
labelled as ‘Major’). In the second case, one splice site
was used preferentially in the wild-type as above, but in
the mutants, use of this splice site increased showing that
the CBC actively promoted usage of the alternative splice
site which generates the minor splice isoform. This
occurred in eight of the remaining cases (Table 4—
labelled ‘Minor’). In two events studied, it was impossible
to point out the major splicing isoform since both
alternative variants occur in equal amounts in wild type
plants. However, the ratio between both splicing isoforms
changed signiﬁcantly in the cbp mutants; in one case use
of the proximal 50ss increased, and in another, use of
the proximal 50ss decreased. Our results show that there
is no preference for the CBC to promote usage of the
50 splice site closest to it, and the CBC, therefore can
promote selection of one or other or both (or more) alter-
native 50 splice sites to increase the levels of alternative
isoforms.
Since in animals, the CBC promotes eﬃcient splicing of
the ﬁrst intron during constitutive splicing we asked
whether it also aﬀects the eﬃciency of intron excision in
plants. To address this, we looked at the six intron reten-
tion events where there was a signiﬁcant change in splicing
in at least one cbp mutant. Of these, two events involved
retention of the ﬁrst intron (At1g01060 and At4g23260)
and two of the second intron (At5g25610 and At2g47890).
Although signiﬁcant in only the cbp80 or the double
mutant, all four showed a decrease in splicing of the
intron. The other two intron retention events aﬀected
the ﬁfth and sixth introns (At3g13224 and At1g69250)
and splicing eﬃciency increased in the mutants aﬀected.
Although only a small number of intron retention events
showed signiﬁcant changes, those involving introns near
the 50 end of the mRNA were less eﬃciently spliced in at
least one mutant suggesting that the CBC may inﬂuence
the eﬃciency of removal of such introns.
DISCUSSION
The nuclear CBC in animal systems promotes an eﬃcient
interaction between the U1snRNP and the ﬁrst intron of a
pre-mRNA transcript, thereby enhancing spliceosome
assembly and the formation of spliced mRNAs. Using
knock-out mutants of the Arabidopsis cap-binding
proteins and an alternative splicing RT–PCR panel, we
have examined the inﬂuence of the CBC on alternative
splicing of multiple diﬀerent pre-mRNAs. The CBC
signiﬁcantly aﬀected (P 0.10) the alternative splicing of
101 events from the 252 analysed and the events involved
introns at diﬀerent positions in the various transcripts.
However, the cbp mutants preferentially aﬀected splicing
within the ﬁrst intron in over half of the AS events which
had signiﬁcant changes in the mutants. In addition, this
eﬀect was preferentially exerted at the 50 splice site consis-
tent with the model for animal systems that the CBC
promotes 50 splice site selection of the ﬁrst intron.
Clearly many internal or last introns also showed an inﬂu-
ence of the CBC on splicing/alternative splicing. Indeed,
when considering events aﬀected in all three mutants,
the proportion of last introns aﬀected increased as well
as the proportion of ﬁrst introns. The eﬀect of the CBC
on introns other than those towards the 50-end of the
mRNA may be the result of indirect regulation of other
splicing factors aﬀecting the splicing of these (and also
some ﬁrst introns) or may reﬂect three-dimensional
interactions in the pre-mRNA. For example, interactions
between the cap and polyadenylation proteins to circular-
ize mRNAs increase translational eﬃciency (60) and have
been suggested to be involved in NMD (61). In addition,
plant genes and particularly introns are much smaller than
those in animal genes (10) potentially permitting a range
of interactions between the CBC and other regions of the
transcript.
An eﬀect of the CBC on alternative splicing has
not been shown previously. Consideration of the model
of the CBC promoting the interaction between the
U1snRNP and 50 splice site of the ﬁrst intron predicts
that, when alternative 50 splice sites are available, the
CBC would promote splicing by recruiting of U1snRNP
to one or other of these sites and potentially to the 50 splice
site nearest to the cap. Our analysis of alternative 50 splice
site selection in ﬁrst introns with signiﬁcant changes in AS
in the cbp mutants showed ﬁrstly that there was no pref-
erence for use of the cap-proximal alternative 50 splice
sites, and secondly, that the CBC either showed a prefer-
ence for one or other site or actively promoted use of a
minor site. Thus, the CBC aﬀected usage of both major
and minor alternative 50 splice sites. This suggests that
while the CBC preferentially aﬀects alternative 50 splice
site selection in the ﬁrst intron, it can promote usage of
both alternative splice sites and thereby inﬂuence the levels
of alternative isoforms. The choice of site and degree of
use are therefore most likely to reﬂect the strength of the
splice sites, possibly the distance of the sites from the cap,
and the presence of splicing enhancer or silencer sequences
and interactions of other splicing factors. This is the ﬁrst
demonstration that the CBC can aﬀect alternative splicing
and is again consistent with the model of the CBC
mediating interactions between the U1 snRNP and 50
splice site of the ﬁrst intron.
Comparison of the eﬀects of the two single mutants and
the double mutant showed that on the basis of the number
of alternatively spliced events analysed here, more AS
events were aﬀected by mutation of AtCBP80(ABH1)
than AtCBP20. This suggests that the larger subunit of
the plant nuclear CBC plays a more signiﬁcant role in
this complex during splicing/alternative splicing regula-
tion. Given that in plants, CBP20 contains the NLSs
and that nuclear import of CBP80 is thought to depend
on CBP20, we expected that mutation of CBP20 would
be more severe in its eﬀects on splicing. However,
although in the single mutants, no AtCBP20 or
AtCBP80 is detected, the protein levels of the remaining
AtCBP80 and AtCBP20 respectively vary. Interestingly, in
the cbp80(abh1) mutant, not only is the CBP80 protein
absent but also the level of AtCBP20 protein is much
reduced suggesting that in the absence of AtCBP80, the
Nucleic AcidsResearch, 2010, Vol.38,No. 1 275AtCBP20 subunit is unstable (48). Thus, the cbp80 mutant
is very similar to the double mutant in terms of the
levels of CBP20 and CBP80 proteins and the splicing
phenotypes of these mutants. In contrast, in the cbp20
mutant which aﬀected fewer of the alternative splicing
events, AtCBP20 was absent but the AtCBP80 protein
was present only at slightly reduced level to wild-type.
This suggests that in the absence of AtCBP20, the larger
subunit may still be able to interact in the splicing process
albeit less eﬃciently. In yeast, CBP20-deﬁcient (cbp20-D)
mutants accumulated amounts of yCBP80 similar to those
observed in the wild type strain, whereas the cbp80-D
strain accumulated four-fold less yCBP20 than the wild
type, suggesting that yCBP20 is unstable in the absence
of yCBP80 (44,62). This observation suggests that protein
interaction with CBP80 may modulate the stability of its
partners. Assuming that AtCBP80 can interact with other
splicing factors, it may still recruit factors to particular
pre-mRNAs and thereby exert a stronger inﬂuence on
splicing than AtCBP20. It was previously shown that
the level of the CBC in the nucleus is precisely regulated
(48) and the composition of the protein bound to the cap
changed dynamically during a growth cycle in Arabidopsis,
playing a role in the regulation of gene expression (63).
Finally, that the single and double mutants are viable
[similar to yeast (42,62)], and that many splicing events
are unaﬀected in the mutants in this analysis, suggests
the splicing of some introns is more dependent on the
CBC than others. This may reﬂect the strength of intron
splicing signals and of splicing enhancer sequences which
can recruit splicing factors without the CBC.
Some splicing alterations were unique to the cbp20 and
the cbp80(abh1) mutants which may reﬂect variation
in the degree of dependence of intron splicing on the cap
or proteins associated with the CBPs or varying ability
of other proteins to compensate in the absence of one
or other of the CBPs. Similarly, some AS changes were
observed in the double mutant only. It is also possible that
loss of one or other or both CBPs aﬀects the splicing/
alternative splicing of transcripts of genes encoding
speciﬁc factors required for splicing of certain genes
thereby indirectly aﬀecting splicing of these genes. The
fact that alternative splicing of transcription and splicing
factors may be regulated by the CBC complex can explain,
at least partially, the growth, developmental and physio-
logical phenotypes of the mutants. In conclusion, in
addition to constitutive splicing, the CBC is involved in
alternative splicing in plants. In both cases, the CBC
preferentially inﬂuences the ﬁrst intron, particularly at
its 50 splice site during alternative splicing in plants.
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